Charles-Antoine Janssen
Co-Founder and Chief Investment Officer @ HealthQuad
Mumbai, India
Charles-Antoine Janssen is an impact investor focused on healthcare access. In 2010, Charles Antoine cofounded KOIS s.a. with François de Borchgrave, a global impact investing firm (blended finance structuring and investment management) active in healthcare, education/skilling and living environments. He is a Managing Partner of KOIS s.a., theCIO of HealthQuad (KOIS / Quadria JV/PE fund focused on Indian healthcare technology and delivery innovations). He is a member of the investment committee of two other KOIS funds: Tara IV (India VC/PE healthcare and social entrepreneurship focus) and Impact Expansion (EU/PE Impact focus).
- Total investments:
- 7
- Last investment:
- Lead investor:
- 86%
Last updated:
For AI agents: llms.txt
Industries Charles-Antoine Janssen invests in
Stages Charles-Antoine Janssen invests in
Countries Charles-Antoine Janssen invests in
Contacts
| Type | Contact | Validation |
|---|---|---|
| Work email | ||
| Personal email | ||
| Work phone | ||
| Personal phone | ||
| Socials |
Investment Focus
Industry
- Health Care 6 (86%)
- Software 3 (43%)
- Wellness 2 (29%)
- Artificial Intelligence 2 (29%)
- B2B 1 (14%)
Stage
- Series B 3 (43%)
- Series A 2 (29%)
- Series C 1 (14%)
Investments
| Company | Description | Round | Links |
|---|---|---|---|
CureSkin
|
CureSkin is a mobile application for derma-care. It is uses computer vision to recommend treatment to patients who don’t have access to trained professionals. | $20M / Series B / Mar 13, 2024 | |
Wysa
|
Wysa provides a mental health wellness platform to help manage stress from health anxiety behavior of employees and patients. Wysa provides early intervention to high-risk groups through an AI chatbot, a library of evidence-based self-help tools, and messaging-based support from human therapists. It blends AI-guided listening with professionalexpert support. | $20M / Series B / Jul 14, 2022 | |
GoApptiv
|
GoApptiv offers end-to-end go-to-market solutions to pharmaceutical companies in India. Our proprietary data analytics tools combined with a network of distribution partners allows us to access these markets in the most cost effective and efficient way possible. HeathTech | Data Analytics | Phygital | $15M / Series A / Jun 28, 2022 | |
Qure AI
|
At Qure.ai their mission is to make healthcare affordable and accessible using the power of artificial intelligence. They build deep learning solutions that aid physicians with routine diagnosis and treatment, allowing them to spend more time with patients. | $40M / Series C / Mar 29, 2022 | |
RED.Health
|
Stanplus Provides 24/7 emergency and medical transportation support.Their fleet 180+ Ambulances can support patients in 15 minutes across Hydrabad, eqquiped with ALS, BLS, Cardiac and Paitent transport Ambulance. | $17.9M / Series A / Jan 24, 2022 | |
|
RED.Health
|
Stanplus Provides 24/7 emergency and medical transportation support.Their fleet 180+ Ambulances can support patients in 15 minutes across Hydrabad, eqquiped with ALS, BLS, Cardiac and Paitent transport Ambulance. | $20.1M / Series A / Jan 24, 2022 | |
Medikabazaar
|
Medikabazaar is an online B2B marketspace for medical supplies and equipment. The company is a single point of contact for all product-based needs, enabling medical institutions and individual practitioners alike to cut down on operational costs and making the best global brands available locally, all aided with the miracle that goes by the name oftechnology. Medikabazaar is connected with more than 50,000 medical establishments, 1,50,000 Independent Practitioners, and have partnered with 13,000+ suppliers all over India including ones in Tier 2, Tier 3 cities, and remoter locations to establish a strong foothold in India.With the power of technology, Medikabazaar organized a haywire market in a country with perhaps the largest and most complex geographical structure in the world for this purpose. Medikabazaar's last-mile delivery system and 26 strategically placed Fulfilment Centers across India enable the company to deliver essential medical supplies to healthcare facilities and help them nurture quality and timely patient care. | $15.6M / Series B / Nov 18, 2019 |
Co-Investors
About HealthQuad
HealthQuad’s investment philosophy is to create value by empowering visionary entrepreneurs building unique solutions that have the potential to redefine the way the society prevents and treats illness. Their approach is defined by “inspired ownership” and they strive to act as a meaningful strategic partner and not just as a financial sponsor.They provide a platform where entrepreneurs can work with us to get not only the capital but also the advice, support, and tools they need to achieve their market potential. In the eyes of the entrepreneurs, they see that the breadth and depth of their expertise, their strong network and their rich ecosystem, are their raison d’être for partnering with us.
HealthQuad Contacts
| Name | Phone | Socials | |
|---|---|---|---|
Ajay Mahipal
Director
|
|||
Abrar Mir
Co-Founder & Advisor
|
|||
|
Amit Varma
Co-Founder & Advisor
|
|||
|
Charles-Antoine Janssen
Co-Founder and Chief Investment Officer
|
|||
|
Charles-Antoine Janssen
Co-Founder and Chief Investment Officer
|
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!
Find investors for your startup
Search 48,091 investors by industry and country. Emails and phones included.
Similar Investors
Similar stage
Recommended lists
FAQ
What does Charles-Antoine Janssen invest in?
Charles-Antoine Janssen invests primarily in Health Care, Software and Wellness startups, most often at Series B and Series A stage. Most of the 7 investments tracked by Shizune back companies in India. The Investment Focus section breaks down every industry, stage and country in the portfolio.
How do I contact Charles-Antoine Janssen?
Public channels for Charles-Antoine Janssen include LinkedIn. For a verified work email and phone number, create a free Shizune account — contact data is searched across 20+ sources and validated before delivery, so your outreach lands in the right inbox.
When did Charles-Antoine Janssen last invest?
The most recent investment recorded for Charles-Antoine Janssen closed in Mar 2024. Shizune tracks 7 investments in total for this profile, including round sizes, stages and portfolio companies, all sourced from confirmed public funding rounds and refreshed monthly.
Is Shizune's investor data accurate?
Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Sep 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.
Contact your first 100 investors today
Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.
Find investors — It's Free!
Continue with Google
Continue with LinkedIn
